award

Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer.

  • Award Number: R21CA280570

  • ORGANIZATION: NATIONAL CANCER INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 05/01/2023

  • PERIOD OF PERFORMANCE END DATE: 04/30/2026